Protective effect of prophylaxis on inhibitor development in children with haemophilia A: More convincing studies are required [5]

British Journal of Haematology

Volumn 132, Issue 6, 2006, Pages 798-799

  Calvez, Thierry ^a   Laurian, Yves ^b,c  

^a INSERM   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c UNIVERSITÉ PARIS 13   (France)

Author keywords

Case control studies; Haemophilia; Inhibitors; Prophylaxis; Time varying risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 8;

BLEEDING; CHILD; DRUG SAFETY; HEMOPHILIA A; HUMAN; LETTER; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; PRIORITY JOURNAL; RISK FACTOR;

EID: 33644905558     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.05989.x     Document Type: Letter

References (6)

1. Lorenzo J.I. Lopez A. Altisent C. Aznar J.A. 2001 Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age British Journal of Haematology 113 600 603
2. Morado M. Villar A. Jimenez Yuste V. Quintana M. Hernandez Navarro F. 2005 Prophylactic treatment effects on inhibitor risk: experience in one centre Haemophilia 11 79 83
3. Nilsson I.M. Berntorp E. Lofqvist T. Pettersson H. 1992 Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B Journal of Internal Medicine 232 25 32
4. Oldenburg J. Picard J.K. Schwaab R. Brackmann H.H. Tuddenham E.G.D. Simpson E. 1997 HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII Thrombosis and Haemostasis 77 238 242
5. Rothman K.J. Greenland S. 1998 Modern Epidemiology 2nd edn pp 97 98 Lippincott-Raven Publishers Philadelphia, PA
6. Santagostino E. Mancuso M.E. Rocino A. Mancuso G. Mazzucconi M.G. Tagliaferri A. Messina M. Mannucci P.M. 2005 Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study British Journal of Haematology 130 422 427